Moderna stock surges over 24% in a single week

Moderna, Inc. shares experienced a significant surge this week, climbing over 24% to close at approximately $198.15. The stock briefly touched levels above $202, breaking through a multi-year resistance zone previously established between $165 and $190.

While no specific major announcement was cited to trigger the jump, the movement aligns with a broader market rotation toward biotechnology and growth stocks. Technical analysis suggests the stock has entered a new phase, with upcoming resistance levels identified between $215 and $260. Analysts note that while a continued rally is possible, a technical pullback to previous support levels could occur.